Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Susan Gross, Christopher Mitton


Natera has appointed Susan Gross chief medical officer. She is a professor of clinical obstetrics and gynecology and women's health, pediatrics and genetics at the Albert Einstein College of Medicine in New York City, where she has served as a member of the faculty since 1994. She is also the founding director of Einstein's Program for Jewish Genetic Health and the founder of the Human Genetics Laboratory at Jacobi Medical Center, which was developed to provide the underserved with equal access to state-of-the-art prenatal genetic services.

Cancer Genetics has appointed Christopher Mitton as director of national account development and sales operations. Previously, he led the North American sales of leukemia and solid tumor molecular diagnostic tests for Qiagen. He has also held diagnostic sales roles at Ipsogen, Bayer HealthCare, Abbott Diagnostics, and BioChem Immunosystems.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.